Antimetastatic effect of nanodiamond-conjugated quercetin against colon cancer: an in vivo study

被引:0
|
作者
Dewi, Firli Rahmah Primula [1 ]
Marviella, Sephia Tiara [1 ]
Wahyuningsih, Sri Puji Astuti [1 ]
Rosyidah, A'liyatur [2 ]
Lim, Vuanghao [3 ]
In, Lionel Lian Aun [4 ]
Saik, Amy Yi Hsan [5 ]
Ariyogo, Bimaji [1 ]
Looi, Mee Lee [6 ]
机构
[1] Univ Airlangga, Fac Sci & Technol, Dept Biol, Surabaya, Indonesia
[2] Natl Res & Innovat Agcy, Res Ctr Vaccine & Drug, Bogor, Indonesia
[3] Univ Sains Malaysia, Adv Med & Dent Inst, Gelugor, Malaysia
[4] Univ Coll Sedaya Int, Fac Appl Sci, Dept Biotechnol, Kuala Lumpur, Malaysia
[5] Univ Tunku Abdul Rahman, M Kandiah Fac Med & Hlth Sci, Dept Preclin Sci, Petaling Jaya, Malaysia
[6] Taylors Univ, Ctr Future Learning, Learning Planning & Dev, Subang Jaya, Malaysia
关键词
Anticancer; quercetin; nanodiamond; colon cancer; metastasis; METASTASIS; RATS; ACID;
D O I
10.55730/1300-0152.2704
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background/aim: Quercetin (Q) is a compound that can inhibit the growth of cancer cells in the colon; however, to do so, a high dose is needed, requiring a drug delivery system to target cancer endothelial cells directly. This study investigates the potency of nanodiamondconjugated quercetin (NDQ) as an anticancer drug against colon cancer in Rattus norvegicus induced by N-methyl N-Nitrosourea (MNU). Materials and methods: This study is experimental-based and was designed using a six-group treatment method, namely normal control (KN: not treated by MNU, nanodiamond (ND), or Q); negative control (K-: treated by MNU); positive control (K+: treated by MNU and capecitabine); ND (treated by MNU and NDs); Q (treated by MNU and Q); and NDQ (treated by MNU and NDQ). To induce colon cancer in rats, MNU (10 mg/Kg BW) was administrated intrarectally three times per week for four weeks. The treatment of Q (40 mg/Kg BW) or NDQ (40 mg/Kg BW) was given intraperitoneally twice a week for 6 weeks. Cancer progression of all cohorts was evaluated by performing body and colon weight measurements, which involved the following: ELISA assay-specific to metastatic marker matrix metalloprotein-9 (MMP-9), carcinoembryonic antigen (CEA), hypoxia-inducible factor 1 alpha (HIF1 alpha), vascular endothelial growth factor, protein 53 (p53) and immunohistochemistry staining of Caspase-3 and Ki-67 proteins. Observation of cancer metastasis to the lung was also performed. Results: NDQ significantly inhibited cancer aggressiveness by causing an increment in body weight gain and the growth rate-while reducing the colon weight compared to the K- group. Moreover, decreased levels of MMP-9, CEA, HIF-1 alpha, and Ki67 and increased levels of p53 and Caspase-3 were more significant in the NDQ group than in the Q group. The lung tumor metastases in the NDQ group were fewer than in the K- group. Conclusion: NDQ increased Q's anticancer activity, suggesting that NDs have an effective drug delivery property.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Targeting EGFR and Monitoring Tumorigenesis of Human Lung Cancer Cells In Vitro and In Vivo Using Nanodiamond-Conjugated Specific EGFR Antibody
    Lin, Yu-Wei
    Su, Hung-Cheng
    Raj, Emmanuel Naveen
    Liu, Kuang-Kai
    Chang, Chien-Jen
    Hsu, Tzu-Chia
    Cheng, Po-Yun
    Wang, Rou-Hsin
    Lai, Yen-Her
    Chen, Chien-Hung
    Lin, Yen-Cheng
    Chao, Jui-, I
    PHARMACEUTICS, 2023, 15 (01)
  • [2] Antimetastatic Activity of Gallic Acid-conjugated Chitosan against Pulmonary Metastasis of Colon Carcinoma Cells
    Lee, Hye Lim
    Choi, Cheol Woong
    Kim, Jungsoo
    Cha, Byungyoul
    Nah, Jae Woon
    Hong, Jeong Sup
    Hwang, Sung Chul
    Jeong, Young-Il
    Kang, Dae Hwan
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2018, 39 (01): : 90 - 96
  • [3] Synthesis of titanium dioxide nanotubes (TNT) conjugated with quercetin and its in vivo antitumor activity against skin cancer
    Gulla, Surendra
    Reddy, Vajra C.
    Araveti, Prasanna Babu
    Lomada, Dakshayani
    Srivastava, Anand
    Reddy, Madhava C.
    Reddy, Kakarla Raghava
    JOURNAL OF MOLECULAR STRUCTURE, 2022, 1249
  • [4] Protective potentiality of Quercetin against colon cancer in Wistar Rats
    Yadav, Vikas
    Sultana, Sarwat
    FREE RADICAL BIOLOGY AND MEDICINE, 2022, 180 : 38 - 39
  • [5] Metabolism of Quercetin In Vivo and Its Protective Effect Against Arteriosclerosis
    Ishizawa, Keisuke
    Yoshizumi, Masanori
    Kawai, Yoshichika
    Terao, Junji
    Kihira, Yoshitaka
    Ikeda, Yasumasa
    Tomita, Shuhei
    Minakuchi, Kazuo
    Tsuchiya, Koichiro
    Tamaki, Toshiaki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 (04) : 466 - 470
  • [6] Metabolism of quercetin in vivo and its protective effect against arteriosclerosis
    Ishizawa, Keisuke
    Yoshizumi, Masanori
    Narantungalag, Dorjsuren
    Imamura, Yuko
    Ikeda, Yasumasa
    Terao, Junji
    Tsuchiya, Koichiro
    Tamaki, Toshiaki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 35P - 35P
  • [7] Effect of lytic peptide conjugated to β LH on ovarian cancer:: In vivo study.
    Gawronska, B
    Leuschner, C
    Enright, FM
    Hansel, W
    BIOLOGY OF REPRODUCTION, 2001, 64 : 228 - 229
  • [8] In vitro and in vivo imaging of colon cancer with cetuximala conjugated fluorescent magnetic nanoparticles
    Cho, Young-seok
    Chang, Kiyuk
    Kim, Hyung-keun
    Yoon, Tae-jong
    GASTROENTEROLOGY, 2007, 132 (04) : A170 - A170
  • [9] The Synthetic Cannabinoid URB447 Exerts Antitumor and Antimetastatic Effect in Melanoma and Colon Cancer
    Benedicto, Aitor
    Arteta, Beatriz
    Duranti, Andrea
    Alonso-Alconada, Daniel
    PHARMACEUTICALS, 2022, 15 (10)
  • [10] Influence of conjugated linoleic acid isomers on the metastasis of colon cancer cells in vitro and in vivo
    Soel, So Mi
    Choi, Ok Sook
    Bang, Myung Hee
    Park, Jung Han Yoon
    Kim, Woo Kyoung
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2007, 18 (10): : 650 - 657